Okla. Stat. tit. 63, § 63-5031: Nonopioid drugs not to be disadvantaged or discouraged

A. As used in this section, “contracted entity” has the same

meaning as provided by Section 4002.2 of Title 56 of the Oklahoma

Statutes.

B. In establishing and maintaining the formulary for the state

Medicaid program, the Oklahoma Health Care Authority shall ensure

that no nonopioid drug approved by the United States Food and Drug

Administration (FDA) for the treatment or management of pain shall

be disadvantaged or discouraged by either the Authority or a

contracted entity with respect to coverage on the formulary relative

to any opioid or narcotic drug for the treatment or management of

pain.

C. When a contracted provider prescribes an FDA-approved

nonopioid drug for the treatment or management of pain, the

Authority or a contracted entity shall not deny coverage of the

nonopioid drug in favor of an opioid drug.

D. This section does not preclude opioid drugs from being

preferred over other opioid drugs or nonopioid drugs from being

preferred over other nonopioid drugs.